SAMHSA is the federal agency responsible for overseeing mental health and substance abuse policies in the United States. It provides leadership in the planning, implementation, and evaluation of these policies, as well as funding for research, treatment, and prevention programs.

The Mental Health Parity and Addiction Equity Act of 2008 aims to ensure that individuals with mental health or substance abuse disorders have equal access to health insurance coverage as those with other medical conditions.

The DEA is responsible for regulating the prescription of controlled substances, including opioids, stimulants, and hallucinogens. It sets quotas for the production and distribution of these substances and enforces laws related to their use and trafficking.

The NSDUH is an annual survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) to collect data on the prevalence of substance use disorders and mental health disorders among adults in the United States.

The ONDCP is responsible for coordinating the nation's response to the opioid crisis. It develops and implements policies and programs to address the crisis, including prevention, treatment, and recovery efforts.

The CARA of 2016 aims to expand access to addiction treatment and recovery services, including medication-assisted treatment, counseling, and peer support. It also provides funding for research on addiction and overdose prevention.

The TTB is responsible for regulating the sale and distribution of alcohol in the United States. It sets standards for alcohol labeling and advertising, and enforces laws related to the sale and taxation of alcohol.

The National Mental Health and Suicide Prevention Lifeline provides free and confidential crisis support and suicide prevention services to individuals in distress. It is available 24/7 by calling 988.

The FDA is responsible for regulating the use of tobacco products, including cigarettes, e-cigarettes, and smokeless tobacco. It sets standards for tobacco product labeling and advertising, and enforces laws related to the sale and taxation of tobacco products.

The SABG provides funding to states and territories for substance abuse prevention and treatment programs. These programs aim to reduce substance abuse and addiction, and to improve the lives of individuals and families affected by substance use disorders.

The FDA is responsible for regulating the use of prescription drugs, including their approval, labeling, and advertising. It also monitors the safety and effectiveness of prescription drugs and takes action to address any safety concerns.

The NSDUH is an annual survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) to collect data on the prevalence of substance use disorders and mental health disorders among adults in the United States.

The ONDCP is responsible for coordinating the nation's response to the opioid crisis. It develops and implements policies and programs to address the crisis, including prevention, treatment, and recovery efforts.

The CARA of 2016 aims to expand access to addiction treatment and recovery services, including medication-assisted treatment, counseling, and peer support. It also provides funding for research on addiction and overdose prevention.

The TTB is responsible for regulating the sale and distribution of alcohol in the United States. It sets standards for alcohol labeling and advertising, and enforces laws related to the sale and taxation of alcohol.